LIVIVO - Search results -

Search results

Result 1 - 10 of total 10

Search options

Article ; Online: Management of the Axilla after Neoadjuvant Systemic Therapy.

Stankowski-Drengler, Trista J / Neuman, Heather B

2020 Volume 21, Issue 7, Page(s) 54

Abstract: Opinion statement: As the use of neoadjuvant systemic therapy (NAST) increases, the optimal management of the axilla has become increasingly complex. Consensus among professional organizations is that those patients with clinically negative axillary ... ...

Abstract	Opinion statement: As the use of neoadjuvant systemic therapy (NAST) increases, the optimal management of the axilla has become increasingly complex. Consensus among professional organizations is that those patients with clinically negative axillary nodes who are being considered for NAST should undergo a sentinel lymph node (SLN) biopsy following NAST. If a positive SLN is subsequently identified, an axillary lymph node dissection (ALND) is the current standard of care. For patients with clinically node-positive disease, SLN biopsy is a reasonable option for those with a good response to NAST. Patients should undergo SLN mapping with a dual dye technique. Additionally, at least 2 lymph nodes should be removed, including the previously biopsied and marked lymph node with cancer. In this setting, the identification and false negative rates are acceptable. Patients found to have a negative SLN at this time may be spared the morbidity associated with ALND. Patients found to have persistently positive lymph nodes following NAST, either clinically or pathologically, should undergo a complete ALND.
MeSH term(s)	Axilla/pathology ; Breast Neoplasms/diagnosis ; Breast Neoplasms/therapy ; Clinical Decision-Making ; Clinical Trials as Topic ; Disease Management ; Female ; Humans ; Lymph Node Excision/methods ; Lymph Nodes/pathology ; Lymphatic Metastasis ; Neoadjuvant Therapy ; Sentinel Lymph Node Biopsy/methods ; Treatment Outcome
Language	English
Publishing date	2020-05-27
Publishing country	United States
Document type	Journal Article ; Research Support, N.I.H., Extramural ; Review
ZDB-ID	2057351-0
ISSN	1534-6277 ; 1527-2729
ISSN (online)	1534-6277
ISSN	1527-2729
DOI	10.1007/s11864-020-00755-7
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 5523: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Details ▾

Article ; Online: Cancer Care Delivery Research: A Path to Improving the Quality of Oncologic Surgical Care.

Stankowski-Drengler, Trista J / Neuman, Heather B

Surgical oncology clinics of North America

2018 Volume 27, Issue 4, Page(s) 653–663

Abstract: The goal of cancer care delivery research (CCDR) is to inform sustainable practice changes that will provide better clinical outcomes and patient experience guided by patient values. CCDR encompasses salient concepts from other well-established research ... ...

Abstract	The goal of cancer care delivery research (CCDR) is to inform sustainable practice changes that will provide better clinical outcomes and patient experience guided by patient values. CCDR encompasses salient concepts from other well-established research approaches and spans the continuum of research from hypothesis generation to effectiveness studies to policy development. CCDR incorporates pertinent attributes, such as saliency to stakeholders, inclusion of diverse participants, and implementation into real-world settings. This article provides examples of CCDR studies, focusing specifically on how CCDR can improve the quality of oncologic surgical care.
MeSH term(s)	Delivery of Health Care/methods ; Health Services Research/methods ; Humans ; Neoplasms/surgery ; Quality of Health Care ; Surgical Oncology/methods
Language	English
Publishing date	2018-07-21
Publishing country	United States
Document type	Journal Article ; Review
ZDB-ID	1196919-2
ISSN	1558-5042 ; 1055-3207
ISSN (online)	1558-5042
ISSN	1055-3207
DOI	10.1016/j.soc.2018.05.006
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Se 1339: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) as a Neoadjuvant Chemotherapy for Non-metastatic Esophageal Cancer (nMEC).

Onitilo, Adedayo A / Stankowski-Drengler, Trista J / Shiyanbola, Oyewale / Engel, Jessica / Tanimu, Sabo / Fagbemi, Seth O / Li, Ya-Huei

Clinical medicine & research

2021 Volume 19, Issue 2, Page(s) 64–71

Abstract: Objective: ...

Abstract	Objective:
MeSH term(s)	Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Cisplatin/therapeutic use ; Docetaxel/therapeutic use ; Esophageal Neoplasms/drug therapy ; Fluorouracil/therapeutic use ; Humans ; Male ; Middle Aged ; Neoadjuvant Therapy ; Retrospective Studies ; Stomach Neoplasms/drug therapy ; Taxoids/therapeutic use
Chemical Substances	Taxoids ; Docetaxel (15H5577CQD) ; Cisplatin (Q20Q21Q62J) ; Fluorouracil (U3P01618RT)
Language	English
Publishing date	2021-03-31
Publishing country	United States
Document type	Journal Article
ZDB-ID	2303793-3
ISSN	1554-6179 ; 1539-4182
ISSN (online)	1554-6179
ISSN	1539-4182
DOI	10.3121/cmr.2021.1573
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 6719: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Utility of health services regions in examining socioeconomic disparities in receipt of breast reconstruction.

Schumacher, Jessica R / Stankowski-Drengler, Trista J / Tucholka, Jennifer L / Poore, Samuel O / Wilke, Lee G / Greenberg, Caprice C / Neuman, Heather B

The breast journal

2020 Volume 26, Issue 9, Page(s) 1895–1897

MeSH term(s)	Breast Neoplasms/surgery ; Female ; Health Services ; Health Services Accessibility ; Healthcare Disparities ; Humans ; Mammaplasty ; Socioeconomic Factors
Language	English
Publishing date	2020-07-01
Publishing country	United States
Document type	Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
ZDB-ID	1289960-4
ISSN	1524-4741 ; 1075-122X
ISSN (online)	1524-4741
ISSN	1075-122X
DOI	10.1111/tbj.13959
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 4483: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: Breast Cancer Outcomes of Neoadjuvant Versus Adjuvant Chemotherapy by Receptor Subtype: A Scoping Review.

Stankowski-Drengler, Trista J / Livingston-Rosanoff, Devon / Schumacher, Jessica R / Hanlon, Bret M / Hitchcock, Mary E / Neuman, Heather B

The Journal of surgical research

2020 Volume 254, Page(s) 83–90

Abstract: Background: Trials demonstrate equivalent survival for breast cancers treated with neoadjuvant chemotherapy (NAC) or adjuvant chemotherapy (AC). However, these were conducted before the recognition of the importance of receptor subtype for survival and ... ...

Abstract	Background: Trials demonstrate equivalent survival for breast cancers treated with neoadjuvant chemotherapy (NAC) or adjuvant chemotherapy (AC). However, these were conducted before the recognition of the importance of receptor subtype for survival and chemotherapy response. Therefore, chemotherapy timing may impact survival for certain receptor subtypes. A scoping review of studies assessing outcomes by chemotherapy timing based on receptor subtype was conducted to evaluate gaps in the existing literature. Methods: Three databases were searched in February 2019 with terms related to breast cancer, NAC/AC, and survival. Inclusion criteria were original peer-reviewed studies published in English after 1989 comparing breast cancer outcomes for females based on chemotherapy timing. Studies/sections of studies lacking outcomes by receptor subtype or including patients missing appropriate targeted therapy were excluded. Results: Of 7354 articles, 262 abstracts and 60 full texts were reviewed. Three studies met criteria. All were single-institution retrospective studies analyzing outcomes for triple negative (TN) patients with one study also examining luminal A patients. Significant differences in clinical characteristics existed between patients selected for NAC versus AC. Two studies demonstrated no survival difference by chemotherapy timing for TN patients, with the third showing improved likelihood of survival after AC for TN patients. No difference was seen for patients with luminal A cancer. Conclusions: Our scoping review reveals a significant gap in the existing literature regarding optimal timing of chemotherapy for modern-era patients receiving targeted therapy based on receptor subtype. Review of the identified studies identified methodological challenges to answering this question through observational study designs.
MeSH term(s)	Breast Neoplasms/chemistry ; Breast Neoplasms/drug therapy ; Breast Neoplasms/mortality ; Chemotherapy, Adjuvant/methods ; Female ; Humans ; Ki-67 Antigen/analysis ; Molecular Targeted Therapy/methods ; Neoadjuvant Therapy/methods ; Neoplasm Recurrence, Local/epidemiology ; Receptors, Cytoplasmic and Nuclear/classification ; Survival Rate ; Time Factors ; Treatment Outcome ; Triple Negative Breast Neoplasms/drug therapy ; Triple Negative Breast Neoplasms/mortality
Chemical Substances	Ki-67 Antigen ; MKI67 protein, human ; Receptors, Cytoplasmic and Nuclear
Language	English
Publishing date	2020-05-15
Publishing country	United States
Document type	Comparative Study ; Journal Article ; Research Support, N.I.H., Extramural ; Review
ZDB-ID	80170-7
ISSN	1095-8673 ; 0022-4804
ISSN (online)	1095-8673
ISSN	0022-4804
DOI	10.1016/j.jss.2020.04.011
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 178: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: Rates of Ipsilateral Local-regional Recurrence in High-risk Patients Undergoing Immediate Post-mastectomy Reconstruction (AFT-01).

Dudley, Christina M / Wiener, Alyssa A / Stankowski-Drengler, Trista J / Schumacher, Jessica R / Francescatti, Amanda B / Poore, Samuel O / Greenberg, Caprice C / Neuman, Heather B

Clinical breast cancer

2021 Volume 21, Issue 5, Page(s) 433–439

Abstract: Background: Some surgeons remain hesitant to perform immediate breast reconstruction (IBR) in patients with higher risk cancers owing to concerns about cancer recurrence and/or detection. Our objective was to determine the rate of ipsilateral local- ... ...

Abstract	Background: Some surgeons remain hesitant to perform immediate breast reconstruction (IBR) in patients with higher risk cancers owing to concerns about cancer recurrence and/or detection. Our objective was to determine the rate of ipsilateral local-regional recurrence for stage II/III patients who underwent IBR. Methods: The National Cancer Database special study mechanism was used to create a stratified sample of women diagnosed with stage II/III breast cancer from 1217 facilities. Demographic, tumor, and recurrence data for women who underwent mastectomy with or without IBR were abstracted, including location of recurrence and method of detection. Estimates of 5-year local-regional recurrence rates were calculated and factors associated with recurrence were identified with multivariable Cox regression. Results: Some 13% (692/5318) of stage II/III patients underwent IBR after mastectomy. Patients undergoing IBR were younger (P < .001), with fewer comorbid conditions (P < .001), and with lower tumor burden in the breast (P = .001) and the lymph nodes (P = 0.01). The 5-year rate of ipsilateral local-regional recurrence was 3.6% with no significant difference between patients with or without IBR (3.0% vs. 3.7%, P = .4). Most recurrences were detected by the patient (45%) or on physician examination (24%). Reconstruction was not associated with recurrence on multivariable analysis (hazard ratio = 0.83, P = .52). Conclusion: Women with stage II/III breast cancer selected for IBR had similar rates of ipsilateral local-regional recurrence compared with those undergoing mastectomy alone. Offering IBR after mastectomy in a patient-centered manner to select patients with stage II/III breast cancer is an acceptable consideration.
MeSH term(s)	Adult ; Breast Neoplasms/mortality ; Breast Neoplasms/surgery ; Disease-Free Survival ; Female ; Follow-Up Studies ; Humans ; Mastectomy/adverse effects ; Mastectomy/methods ; Mastectomy/mortality ; Middle Aged ; Neoplasm Recurrence, Local/mortality ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/prevention & control ; Risk Factors
Language	English
Publishing date	2021-03-27
Publishing country	United States
Document type	Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
ZDB-ID	2106734-X
ISSN	1938-0666 ; 1526-8209
ISSN (online)	1938-0666
ISSN	1526-8209
DOI	10.1016/j.clbc.2021.03.009
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 5800: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG)
Zs.MO 498: Show issues

Order via subito

Details ▾

Article ; Online: Breast Cancer Found Incidentally After Reduction Mammaplasty in Young Insured Women.

Vande Walle, Kara / Yang, Dou-Yan Y / Stankowski-Drengler, Trista J / Livingston-Rosanoff, Devon / Fernandes-Taylor, Sara / Schumacher, Jessica R / Wilke, Lee G / Greenberg, Caprice C / Neuman, Heather B

Annals of surgical oncology

2019 Volume 26, Issue 13, Page(s) 4310–4316

Abstract: Background: Reduction mammaplasty is a common operation performed for healthy women. The estimated incidence of breast cancer diagnosed at the time of reduction mammaplasty varies from 0.06 to 4.5%, and information on the care of these patients is ... ...

Abstract	Background: Reduction mammaplasty is a common operation performed for healthy women. The estimated incidence of breast cancer diagnosed at the time of reduction mammaplasty varies from 0.06 to 4.5%, and information on the care of these patients is limited. This study aimed to determine the incidence of breast cancer identified incidentally during reduction mammaplasty and to characterize preoperative imaging. Methods: Women 18 years of age or older who underwent reduction mammaplasty from 2013 to 2015 were identified from the Truven Health MarketScan Results: Reduction mammaplasty was performed for 18,969 women with a mean age of 42.5 years. Of these patients, 186 (0.98%) were incidentally found to have breast cancer, with 134 (0.71%) having invasive breast cancer and 52 (0.27%) having carcinoma in situ. The patients with incidentally found cancer were older than the patients without cancer (50.8 vs. 42.5 years; p < 0.001). Overall, 58.2% of the patients had undergone mammography before reduction mammoplasty. The rates were higher (> 80%) for the patients older than 40 years. Preoperative mammography was performed for 76.3% of those with a diagnosis of breast cancer at time of reduction mammoplasty. Conclusions: Breast cancer diagnosed incidentally at the time of reduction mammaplasty is uncommon and often radiographically occult. The majority of women older than 50 years appropriately received preoperative mammography. These data can be used to manage patient expectations about the potential for the incidental diagnosis of breast cancer at reduction mammaplasty, even with a negative preoperative mammography.
MeSH term(s)	Adult ; Breast Neoplasms/diagnosis ; Breast Neoplasms/diagnostic imaging ; Breast Neoplasms/surgery ; Carcinoma in Situ/diagnosis ; Carcinoma in Situ/diagnostic imaging ; Carcinoma in Situ/surgery ; Female ; Follow-Up Studies ; Humans ; Incidental Findings ; Insurance, Health ; Magnetic Resonance Imaging/methods ; Mammaplasty/statistics & numerical data ; Mammography ; Middle Aged ; Postoperative Care ; Prognosis ; Ultrasonography, Mammary/methods
Language	English
Publishing date	2019-09-19
Publishing country	United States
Document type	Journal Article
ZDB-ID	1200469-8
ISSN	1534-4681 ; 1068-9265
ISSN (online)	1534-4681
ISSN	1068-9265
DOI	10.1245/s10434-019-07726-9
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 4042: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: A Randomized Controlled Trial Evaluating the Impact of Pre-Consultation Information on Patients' Perception of Information Conveyed and Satisfaction with the Decision-Making Process.

Stankowski-Drengler, Trista J / Tucholka, Jennifer L / Bruce, Jordan G / Steffens, Nicole M / Schumacher, Jessica R / Greenberg, Caprice C / Wilke, Lee G / Hanlon, Bret / Steiman, Jennifer / Neuman, Heather B

Annals of surgical oncology

2019 Volume 26, Issue 10, Page(s) 3275–3281

Abstract: Background: Patient participation in treatment decision-making is a health care priority. This study hypothesized that providing a decision aid before surgical consultation would better prepare patients for decision-making. The objective was to examine ... ...

Abstract	Background: Patient participation in treatment decision-making is a health care priority. This study hypothesized that providing a decision aid before surgical consultation would better prepare patients for decision-making. The objective was to examine the impact of a decision aid versus high-quality websites on patients' perceptions of information conveyed during surgical consultation and satisfaction with the decision process. Methods: Patients with stages 0 to 3 breast cancer were randomized. Surveys assessed perceptions of information conveyed, being asked surgical preference, and satisfaction with the decision process. Multivariable logistic regression assessed associations between outcomes and randomization arm, patient factors, and surgeon. Change in Pseudo-R Results: The median patient age was 59 years. Most of the patients (98%) were white, and 62% were college educated (n = 201). The findings showed no association between randomization arm and perceptions of information conveyed, being asked surgical preference, or satisfaction with the decision process. Most of the patients reported discussing both breast-conserving therapy and mastectomy (69%) and being asked their surgical preference (65%). The surgeon seen was more important than the randomization arm or the patient factors in predicting patients' perceptions of information conveyed (explained 64-69% of the variation), and 63% of the patients were satisfied with the decision process. Conclusion: Use of a decision aid compared with high-quality websites did not increase patients' perceptions of information conveyed or satisfaction with the decision process. Although the surgeon seen influenced aspects of the patient experience, the surgeon was not associated with satisfaction. Understanding the factors driving low satisfaction is critical because this is increasingly used as a marker of health care quality.
MeSH term(s)	Adult ; Aged ; Aged, 80 and over ; Breast Neoplasms/surgery ; Decision Making ; Decision Support Techniques ; Female ; Follow-Up Studies ; Health Knowledge, Attitudes, Practice ; Humans ; Information Dissemination/methods ; Internet/statistics & numerical data ; Middle Aged ; Patient Education as Topic ; Patient Satisfaction ; Physician-Patient Relations ; Prognosis ; Referral and Consultation
Language	English
Publishing date	2019-07-24
Publishing country	United States
Document type	Journal Article ; Randomized Controlled Trial
ZDB-ID	1200469-8
ISSN	1534-4681 ; 1068-9265
ISSN (online)	1534-4681
ISSN	1068-9265
DOI	10.1245/s10434-019-07535-0
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 4042: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: All-cause mortality is decreased in women undergoing annual mammography before breast cancer diagnosis.

Engel, Jessica M / Stankowski-Drengler, Trista J / Stankowski, Rachel V / Liang, Hong / Doi, Suhail A / Onitilo, Adedayo A

AJR. American journal of roentgenology

2015 Volume 204, Issue 4, Page(s) 898–902

Abstract: Objective: The value of annual mammography remains an area of debate because of concerns regarding risk versus benefit. The potential for harm due to overdiagnosis and treatment of clinically insignificant cancers may not be captured by breast cancer- ... ...

Abstract	Objective: The value of annual mammography remains an area of debate because of concerns regarding risk versus benefit. The potential for harm due to overdiagnosis and treatment of clinically insignificant cancers may not be captured by breast cancer-specific mortality. Instead, we examined all-cause mortality as a function of missed annual mammography examinations before breast cancer diagnosis. Materials and methods: Primary breast cancer cases diagnosed in the Marsh-field Clinic Health System from 2002 through 2008 were identified for retrospective review, and whether annual mammography examinations had been performed in the 5 years before diagnosis was assessed. Results: Analyses were performed on 1421 women with breast cancer. After adjustment of data for age, comorbidity status, a family history of breast cancer, insurance status, medical encounter frequency, and the calendar year, women who had missed any of the previous five annual mammography examinations had a 2.3-fold increased risk of all-cause mortality compared with subjects with no missed mammography examinations (hazard ratio=2.28; 95% CI, 1.58-3.30; p<0.0001). Additionally, an analysis by the number of missed annual mammography examinations showed a progressive increase in hazard as the number of missed mammography studies increased. Conclusion: These results suggest that annual mammography before breast cancer diagnosis is predictive of increased overall survival. A stepwise decline in overall survival was noted for each additional missed mammography examination. These results are similar to findings in the literature for breast cancer-specific mortality and illustrate the importance of recommending annual mammography to all eligible women.
MeSH term(s)	Aged ; Breast Neoplasms/diagnostic imaging ; Breast Neoplasms/mortality ; Cause of Death ; Female ; Humans ; Mammography/utilization ; Middle Aged ; Predictive Value of Tests ; Retrospective Studies ; Survival Analysis ; Wisconsin/epidemiology
Language	English
Publishing date	2015-04
Publishing country	United States
Document type	Journal Article
ZDB-ID	82076-3
ISSN	1546-3141 ; 0361-803X ; 0092-5381
ISSN (online)	1546-3141
ISSN	0361-803X ; 0092-5381
DOI	10.2214/AJR.14.12666
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Ue I Zs.57: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Specificity of serum and urine protein electrophoresis for the diagnosis of monoclonal gammopathies.

Katzmann, Jerry A / Stankowski-Drengler, Trista J / Kyle, Robert A / Karen, S Lockington / Snyder, Melissa R / Lust, John A / Dispenzieri, Angela

Clinical chemistry

2010 Volume 56, Issue 12, Page(s) 1899–1900

MeSH term(s)	Agammaglobulinemia/blood ; Agammaglobulinemia/urine ; Blood Protein Electrophoresis ; Humans ; Immunoglobulin Heavy Chains/blood ; Immunoglobulin Heavy Chains/urine ; Immunoglobulin Light Chains/blood ; Immunoglobulin Light Chains/urine ; Immunoglobulins/blood ; Immunoglobulins/urine ; Paraproteinemias/blood ; Paraproteinemias/diagnosis ; Paraproteinemias/urine
Chemical Substances	Immunoglobulin Heavy Chains ; Immunoglobulin Light Chains ; Immunoglobulins
Language	English
Publishing date	2010-09-15
Publishing country	England
Document type	Letter
ZDB-ID	80102-1
ISSN	1530-8561 ; 0009-9147
ISSN (online)	1530-8561
ISSN	0009-9147
DOI	10.1373/clinchem.2010.152280
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Ud II Zs.171: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

To top

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito